1 Preventable Vaccines Market Overview 1.1 Preventable Vaccines Product Scope 1.2 Preventable Vaccines Segment by Type 1.2.1 Global Preventable Vaccines Sales by Type (2016 & 2021 & 2027) 1.2.2 Adult Preventable Vaccines 1.2.3 Pediatric Preventable Vaccines 1.3 Preventable Vaccines Segment by Application 1.3.1 Global Preventable Vaccines Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Bacterial Diseases 1.3.3 Virus Diseases 1.4 Preventable Vaccines Market Estimates and Forecasts (2016-2027) 1.4.1 Global Preventable Vaccines Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Preventable Vaccines Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Preventable Vaccines Price Trends (2016-2027) 2 Preventable Vaccines Estimates and Forecasts by Region 2.1 Global Preventable Vaccines Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Preventable Vaccines Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Preventable Vaccines Sales Market Share by Region (2016-2021) 2.2.2 Global Preventable Vaccines Revenue Market Share by Region (2016-2021) 2.3 Global Preventable Vaccines Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Preventable Vaccines Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Preventable Vaccines Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Preventable Vaccines Estimates and Projections (2016-2027) 2.4.2 Europe Preventable Vaccines Estimates and Projections (2016-2027) 2.4.3 China Preventable Vaccines Estimates and Projections (2016-2027) 2.4.4 Japan Preventable Vaccines Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Preventable Vaccines Estimates and Projections (2016-2027) 2.4.6 India Preventable Vaccines Estimates and Projections (2016-2027) 3 Global Preventable Vaccines Competition Landscape by Players 3.1 Global Top Preventable Vaccines Players by Sales (2016-2021) 3.2 Global Top Preventable Vaccines Players by Revenue (2016-2021) 3.3 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2020) 3.4 Global Preventable Vaccines Average Price by Company (2016-2021) 3.5 Manufacturers Preventable Vaccines Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Preventable Vaccines Market Size by Type 4.1 Global Preventable Vaccines Historic Market Review by Type (2016-2021) 4.1.1 Global Preventable Vaccines Sales Market Share by Type (2016-2021) 4.1.2 Global Preventable Vaccines Revenue Market Share by Type (2016-2021) 4.1.3 Global Preventable Vaccines Price by Type (2016-2021) 4.2 Global Preventable Vaccines Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Preventable Vaccines Sales Forecast by Type (2022-2027) 4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2022-2027) 4.2.3 Global Preventable Vaccines Price Forecast by Type (2022-2027) 5 Global Preventable Vaccines Market Size by Application 5.1 Global Preventable Vaccines Historic Market Review by Application (2016-2021) 5.1.1 Global Preventable Vaccines Sales Market Share by Application (2016-2021) 5.1.2 Global Preventable Vaccines Revenue Market Share by Application (2016-2021) 5.1.3 Global Preventable Vaccines Price by Application (2016-2021) 5.2 Global Preventable Vaccines Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Preventable Vaccines Sales Forecast by Application (2022-2027) 5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2022-2027) 5.2.3 Global Preventable Vaccines Price Forecast by Application (2022-2027) 6 North America Preventable Vaccines Market Facts & Figures 6.1 North America Preventable Vaccines Sales by Company 6.1.1 North America Preventable Vaccines Sales by Company (2016-2021) 6.1.2 North America Preventable Vaccines Revenue by Company (2016-2021) 6.2 North America Preventable Vaccines Sales Breakdown by Type 6.2.1 North America Preventable Vaccines Sales Breakdown by Type (2016-2021) 6.2.2 North America Preventable Vaccines Sales Breakdown by Type (2022-2027) 6.3 North America Preventable Vaccines Sales Breakdown by Application 6.3.1 North America Preventable Vaccines Sales Breakdown by Application (2016-2021) 6.3.2 North America Preventable Vaccines Sales Breakdown by Application (2022-2027) 7 Europe Preventable Vaccines Market Facts & Figures 7.1 Europe Preventable Vaccines Sales by Company 7.1.1 Europe Preventable Vaccines Sales by Company (2016-2021) 7.1.2 Europe Preventable Vaccines Revenue by Company (2016-2021) 7.2 Europe Preventable Vaccines Sales Breakdown by Type 7.2.1 Europe Preventable Vaccines Sales Breakdown by Type (2016-2021) 7.2.2 Europe Preventable Vaccines Sales Breakdown by Type (2022-2027) 7.3 Europe Preventable Vaccines Sales Breakdown by Application 7.3.1 Europe 154 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 154 Sales Breakdown by Application (2022-2027) 8 China Preventable Vaccines Market Facts & Figures 8.1 China Preventable Vaccines Sales by Company 8.1.1 China Preventable Vaccines Sales by Company (2016-2021) 8.1.2 China Preventable Vaccines Revenue by Company (2016-2021) 8.2 China Preventable Vaccines Sales Breakdown by Type 8.2.1 China Preventable Vaccines Sales Breakdown by Type (2016-2021) 8.2.2 China Preventable Vaccines Sales Breakdown by Type (2022-2027) 8.3 China Preventable Vaccines Sales Breakdown by Application 8.3.1 China 171 Sales Breakdown by Application (2016-2021) 8.3.2 China 171 Sales Breakdown by Application (2022-2027) 9 Japan Preventable Vaccines Market Facts & Figures 9.1 Japan Preventable Vaccines Sales by Company 9.1.1 Japan Preventable Vaccines Sales by Company (2016-2021) 9.1.2 Japan Preventable Vaccines Revenue by Company (2016-2021) 9.2 Japan Preventable Vaccines Sales Breakdown by Type 9.2.1 Japan Preventable Vaccines Sales Breakdown by Type (2016-2021) 9.2.2 Japan Preventable Vaccines Sales Breakdown by Type (2022-2027) 9.3 Japan Preventable Vaccines Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Preventable Vaccines Market Facts & Figures 10.1 Southeast Asia Preventable Vaccines Sales by Company 10.1.1 Southeast Asia Preventable Vaccines Sales by Company (2016-2021) 10.1.2 Southeast Asia Preventable Vaccines Revenue by Company (2016-2021) 10.2 Southeast Asia Preventable Vaccines Sales Breakdown by Type 10.2.1 Southeast Asia Preventable Vaccines Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Preventable Vaccines Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Preventable Vaccines Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Preventable Vaccines Market Facts & Figures 11.1 India Preventable Vaccines Sales by Company 11.1.1 India Preventable Vaccines Sales by Company (2016-2021) 11.1.2 India Preventable Vaccines Revenue by Company (2016-2021) 11.2 India Preventable Vaccines Sales Breakdown by Type 11.2.1 India Preventable Vaccines Sales Breakdown by Type (2016-2021) 11.2.2 India Preventable Vaccines Sales Breakdown by Type (2022-2027) 11.3 India Preventable Vaccines Sales Breakdown by Application 11.3.1 India Preventable Vaccines Sales Breakdown by Application (2016-2021) 11.3.2 India Preventable Vaccines Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Preventable Vaccines Business 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Business Overview 12.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GlaxoSmithKline Preventable Vaccines Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Merck 12.2.1 Merck Corporation Information 12.2.2 Merck Business Overview 12.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Merck Preventable Vaccines Products Offered 12.2.5 Merck Recent Development 12.3 Novartis 12.3.1 Novartis Corporation Information 12.3.2 Novartis Business Overview 12.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Novartis Preventable Vaccines Products Offered 12.3.5 Novartis Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Business Overview 12.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Preventable Vaccines Products Offered 12.4.5 Pfizer Recent Development 12.5 Sanofi 12.5.1 Sanofi Corporation Information 12.5.2 Sanofi Business Overview 12.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Sanofi Preventable Vaccines Products Offered 12.5.5 Sanofi Recent Development 12.6 Takeda Pharmaceutical 12.6.1 Takeda Pharmaceutical Corporation Information 12.6.2 Takeda Pharmaceutical Business Overview 12.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered 12.6.5 Takeda Pharmaceutical Recent Development 12.7 Abbott 12.7.1 Abbott Corporation Information 12.7.2 Abbott Business Overview 12.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Abbott Preventable Vaccines Products Offered 12.7.5 Abbott Recent Development 12.8 Roche 12.8.1 Roche Corporation Information 12.8.2 Roche Business Overview 12.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Roche Preventable Vaccines Products Offered 12.8.5 Roche Recent Development 12.9 AstraZeneca 12.9.1 AstraZeneca Corporation Information 12.9.2 AstraZeneca Business Overview 12.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.9.4 AstraZeneca Preventable Vaccines Products Offered 12.9.5 AstraZeneca Recent Development 12.10 Mitsubishi Tanabe Pharma 12.10.1 Mitsubishi Tanabe Pharma Corporation Information 12.10.2 Mitsubishi Tanabe Pharma Business Overview 12.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered 12.10.5 Mitsubishi Tanabe Pharma Recent Development 12.11 Lupin 12.11.1 Lupin Corporation Information 12.11.2 Lupin Business Overview 12.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Lupin Preventable Vaccines Products Offered 12.11.5 Lupin Recent Development 12.12 Serum Institute of India 12.12.1 Serum Institute of India Corporation Information 12.12.2 Serum Institute of India Business Overview 12.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Serum Institute of India Preventable Vaccines Products Offered 12.12.5 Serum Institute of India Recent Development 12.13 LG Life Sciences 12.13.1 LG Life Sciences Corporation Information 12.13.2 LG Life Sciences Business Overview 12.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.13.4 LG Life Sciences Preventable Vaccines Products Offered 12.13.5 LG Life Sciences Recent Development 12.14 S K Chemicals 12.14.1 S K Chemicals Corporation Information 12.14.2 S K Chemicals Business Overview 12.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.14.4 S K Chemicals Preventable Vaccines Products Offered 12.14.5 S K Chemicals Recent Development 12.15 Shenzhen Kangtai Biological Products 12.15.1 Shenzhen Kangtai Biological Products Corporation Information 12.15.2 Shenzhen Kangtai Biological Products Business Overview 12.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products Offered 12.15.5 Shenzhen Kangtai Biological Products Recent Development 12.16 Sinovac Biotech 12.16.1 Sinovac Biotech Corporation Information 12.16.2 Sinovac Biotech Business Overview 12.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Sinovac Biotech Preventable Vaccines Products Offered 12.16.5 Sinovac Biotech Recent Development 12.17 Janssen Pharmaceuticals 12.17.1 Janssen Pharmaceuticals Corporation Information 12.17.2 Janssen Pharmaceuticals Business Overview 12.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Janssen Pharmaceuticals Preventable Vaccines Products Offered 12.17.5 Janssen Pharmaceuticals Recent Development 12.18 Crucell 12.18.1 Crucell Corporation Information 12.18.2 Crucell Business Overview 12.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Crucell Preventable Vaccines Products Offered 12.18.5 Crucell Recent Development 12.19 Bavarian Nordic 12.19.1 Bavarian Nordic Corporation Information 12.19.2 Bavarian Nordic Business Overview 12.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Bavarian Nordic Preventable Vaccines Products Offered 12.19.5 Bavarian Nordic Recent Development 12.20 Baxter 12.20.1 Baxter Corporation Information 12.20.2 Baxter Business Overview 12.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Baxter Preventable Vaccines Products Offered 12.20.5 Baxter Recent Development 12.21 Bharat Biotech 12.21.1 Bharat Biotech Corporation Information 12.21.2 Bharat Biotech Business Overview 12.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Bharat Biotech Preventable Vaccines Products Offered 12.21.5 Bharat Biotech Recent Development 12.22 Dynavax 12.22.1 Dynavax Corporation Information 12.22.2 Dynavax Business Overview 12.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Dynavax Preventable Vaccines Products Offered 12.22.5 Dynavax Recent Development 12.23 Bausch Health 12.23.1 Bausch Health Corporation Information 12.23.2 Bausch Health Business Overview 12.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Bausch Health Preventable Vaccines Products Offered 12.23.5 Bausch Health Recent Development 12.24 Protein Sciences 12.24.1 Protein Sciences Corporation Information 12.24.2 Protein Sciences Business Overview 12.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Protein Sciences Preventable Vaccines Products Offered 12.24.5 Protein Sciences Recent Development 12.25 Panacea Biotec 12.25.1 Panacea Biotec Corporation Information 12.25.2 Panacea Biotec Business Overview 12.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Panacea Biotec Preventable Vaccines Products Offered 12.25.5 Panacea Biotec Recent Development 13 Preventable Vaccines Manufacturing Cost Analysis 13.1 Preventable Vaccines Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Preventable Vaccines 13.4 Preventable Vaccines Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Preventable Vaccines Distributors List 14.3 Preventable Vaccines Customers 15 Market Dynamics 15.1 Preventable Vaccines Market Trends 15.2 Preventable Vaccines Drivers 15.3 Preventable Vaccines Market Challenges 15.4 Preventable Vaccines Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Preventable Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Preventable Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Preventable Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Preventable Vaccines Sales (K Units) by Region (2016-2021) Table 5. Global Preventable Vaccines Sales Market Share by Region (2016-2021) Table 6. Global Preventable Vaccines Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Preventable Vaccines Revenue Share by Region (2016-2021) Table 8. Global Preventable Vaccines Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Preventable Vaccines Sales Market Share Forecast by Region (2022-2027) Table 10. Global Preventable Vaccines Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Preventable Vaccines Revenue Share Forecast by Region (2022-2027) Table 12. Global Preventable Vaccines Sales (K Units) of Key Companies (2016-2021) Table 13. Global Preventable Vaccines Sales Share by Company (2016-2021) Table 14. Global Preventable Vaccines Revenue (US$ Million) by Company (2016-2021) Table 15. Global Preventable Vaccines Revenue Share by Company (2016-2021) Table 16. Global Preventable Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventable Vaccines as of 2020) Table 17. Global Preventable Vaccines Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Preventable Vaccines Manufacturing Sites and Area Served Table 19. Manufacturers Preventable Vaccines Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Preventable Vaccines Sales (K Units) by Type (2016-2021) Table 22. Global Preventable Vaccines Sales Share by Type (2016-2021) Table 23. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Preventable Vaccines Price (USD/Unit) by Type (2016-2021) Table 25. Global Preventable Vaccines Sales Share by Type (2022-2027) Table 26. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Preventable Vaccines Revenue Share by Type (2022-2027) Table 28. Global Preventable Vaccines Price (USD/Unit) by Type (2022-2027) Table 29. Global Preventable Vaccines Sales (K Units) by Application (2016-2021) Table 30. Global Preventable Vaccines Sales Share by Application (2016-2021) Table 31. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Preventable Vaccines Price (USD/Unit) by Application (2016-2021) Table 33. Global Preventable Vaccines Sales (K Units) by Application (2022-2027) Table 34. Global Preventable Vaccines Sales Share by Application (2022-2027) Table 35. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Preventable Vaccines Revenue Share by Application (2022-2027) Table 37. Global Preventable Vaccines Price (USD/Unit) by Application (2022-2027) Table 38. North America Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 39. North America Preventable Vaccines Sales Market Share by Company (2016-2021) Table 40. North America Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 42. North America Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 43. North America Preventable Vaccines Sales Market Share by Type (2016-2021) Table 44. North America Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 45. North America Preventable Vaccines Sales Market Share by Type (2022-2027) Table 46. North America Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 47. North America Preventable Vaccines Sales Market Share by Application (2016-2021) Table 48. North America Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 49. North America Preventable Vaccines Sales Market Share by Application (2022-2027) Table 50. Europe Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 51. Europe Preventable Vaccines Sales Market Share by Company (2016-2021) Table 52. Europe Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 54. Europe Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 55. Europe Preventable Vaccines Sales Market Share by Type (2016-2021) Table 56. Europe Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 57. Europe Preventable Vaccines Sales Market Share by Type (2022-2027) Table 58. Europe Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 59. Europe Preventable Vaccines Sales Market Share by Application (2016-2021) Table 60. Europe Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 61. Europe Preventable Vaccines Sales Market Share by Application (2022-2027) Table 62. China Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 63. China Preventable Vaccines Sales Market Share by Company (2016-2021) Table 64. China Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 65. China Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 66. China Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 67. China Preventable Vaccines Sales Market Share by Type (2016-2021) Table 68. China Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 69. China Preventable Vaccines Sales Market Share by Type (2022-2027) Table 70. China Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 71. China Preventable Vaccines Sales Market Share by Application (2016-2021) Table 72. China Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 73. China Preventable Vaccines Sales Market Share by Application (2022-2027) Table 74. Japan Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 75. Japan Preventable Vaccines Sales Market Share by Company (2016-2021) Table 76. Japan Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 78. Japan Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 79. Japan Preventable Vaccines Sales Market Share by Type (2016-2021) Table 80. Japan Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 81. Japan Preventable Vaccines Sales Market Share by Type (2022-2027) Table 82. Japan Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 83. Japan Preventable Vaccines Sales Market Share by Application (2016-2021) Table 84. Japan Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 85. Japan Preventable Vaccines Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Preventable Vaccines Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Preventable Vaccines Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Preventable Vaccines Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Preventable Vaccines Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Preventable Vaccines Sales Market Share by Application (2022-2027) Table 98. India Preventable Vaccines Sales (K Units) by Company (2016-2021) Table 99. India Preventable Vaccines Sales Market Share by Company (2016-2021) Table 100. India Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 101. India Preventable Vaccines Revenue Market Share by Company (2016-2021) Table 102. India Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 103. India Preventable Vaccines Sales Market Share by Type (2016-2021) Table 104. India Preventable Vaccines Sales by Type (2022-2027) & (K Units) Table 105. India Preventable Vaccines Sales Market Share by Type (2022-2027) Table 106. India Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 107. India Preventable Vaccines Sales Market Share by Application (2016-2021) Table 108. India Preventable Vaccines Sales by Application (2022-2027) & (K Units) Table 109. India Preventable Vaccines Sales Market Share by Application (2022-2027) Table 110. GlaxoSmithKline Corporation Information Table 111. GlaxoSmithKline Description and Business Overview Table 112. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. GlaxoSmithKline Preventable Vaccines Product Table 114. GlaxoSmithKline Recent Development Table 115. Merck Corporation Information Table 116. Merck Description and Business Overview Table 117. Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Merck Preventable Vaccines Product Table 119. Merck Recent Development Table 120. Novartis Corporation Information Table 121. Novartis Description and Business Overview Table 122. Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Novartis Preventable Vaccines Product Table 124. Novartis Recent Development Table 125. Pfizer Corporation Information Table 126. Pfizer Description and Business Overview Table 127. Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Pfizer Preventable Vaccines Product Table 129. Pfizer Recent Development Table 130. Sanofi Corporation Information Table 131. Sanofi Description and Business Overview Table 132. Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Sanofi Preventable Vaccines Product Table 134. Sanofi Recent Development Table 135. Takeda Pharmaceutical Corporation Information Table 136. Takeda Pharmaceutical Description and Business Overview Table 137. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Takeda Pharmaceutical Preventable Vaccines Product Table 139. Takeda Pharmaceutical Recent Development Table 140. Abbott Corporation Information Table 141. Abbott Description and Business Overview Table 142. Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Abbott Preventable Vaccines Product Table 144. Abbott Recent Development Table 145. Roche Corporation Information Table 146. Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Roche Description and Business Overview Table 148. Roche Preventable Vaccines Product Table 149. Roche Recent Development Table 150. AstraZeneca Corporation Information Table 151. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. AstraZeneca Description and Business Overview Table 153. AstraZeneca Preventable Vaccines Product Table 154. AstraZeneca Recent Development Table 155. Mitsubishi Tanabe Pharma Corporation Information Table 156. Mitsubishi Tanabe Pharma Description and Business Overview Table 157. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Mitsubishi Tanabe Pharma Preventable Vaccines Product Table 159. Mitsubishi Tanabe Pharma Recent Development Table 160. Lupin Corporation Information Table 161. Lupin Description and Business Overview Table 162. Lupin Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Lupin Preventable Vaccines Product Table 164. Lupin Recent Development Table 165. Serum Institute of India Corporation Information Table 166. Serum Institute of India Description and Business Overview Table 167. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 168. Serum Institute of India Preventable Vaccines Product Table 169. Serum Institute of India Recent Development Table 170. LG Life Sciences Corporation Information Table 171. LG Life Sciences Description and Business Overview Table 172. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 173. LG Life Sciences Preventable Vaccines Product Table 174. LG Life Sciences Recent Development Table 175. S K Chemicals Corporation Information Table 176. S K Chemicals Description and Business Overview Table 177. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 178. S K Chemicals Preventable Vaccines Product Table 179. S K Chemicals Recent Development Table 180. Shenzhen Kangtai Biological Products Corporation Information Table 181. Shenzhen Kangtai Biological Products Description and Business Overview Table 182. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 183. Shenzhen Kangtai Biological Products Preventable Vaccines Product Table 184. Shenzhen Kangtai Biological Products Recent Development Table 185. Sinovac Biotech Corporation Information Table 186. Sinovac Biotech Description and Business Overview Table 187. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 188. Sinovac Biotech Preventable Vaccines Product Table 189. Sinovac Biotech Recent Development Table 190. Janssen Pharmaceuticals Corporation Information Table 191. Janssen Pharmaceuticals Description and Business Overview Table 192. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 193. Janssen Pharmaceuticals Preventable Vaccines Product Table 194. Janssen Pharmaceuticals Recent Development Table 195. Crucell Corporation Information Table 196. Crucell Description and Business Overview Table 197. Crucell Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 198. Crucell Preventable Vaccines Product Table 199. Crucell Recent Development Table 200. Bavarian Nordic Corporation Information Table 201. Bavarian Nordic Description and Business Overview Table 202. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 203. Bavarian Nordic Preventable Vaccines Product Table 204. Bavarian Nordic Recent Development Table 205. Baxter Corporation Information Table 206. Baxter Description and Business Overview Table 207. Baxter Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 208. Baxter Preventable Vaccines Product Table 209. Baxter Recent Development Table 210. Bharat Biotech Corporation Information Table 211. Bharat Biotech Description and Business Overview Table 212. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 213. Bharat Biotech Preventable Vaccines Product Table 214. Bharat Biotech Recent Development Table 215. Dynavax Corporation Information Table 216. Dynavax Description and Business Overview Table 217. Dynavax Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 218. Dynavax Preventable Vaccines Product Table 219. Dynavax Recent Development Table 220. Bausch Health Corporation Information Table 221. Bausch Health Description and Business Overview Table 222. Bausch Health Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 223. Bausch Health Preventable Vaccines Product Table 224. Bausch Health Recent Development Table 225. Protein Sciences Corporation Information Table 226. Protein Sciences Description and Business Overview Table 227. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 228. Protein Sciences Preventable Vaccines Product Table 229. Protein Sciences Recent Development Table 230. Panacea Biotec Corporation Information Table 231. Panacea Biotec Description and Business Overview Table 232. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 233. Panacea Biotec Preventable Vaccines Product Table 234. Panacea Biotec Recent Development Table 235. Production Base and Market Concentration Rate of Raw Material Table 236. Key Suppliers of Raw Materials Table 237. Preventable Vaccines Distributors List Table 238. Preventable Vaccines Customers List Table 239. Preventable Vaccines Market Trends Table 240. Preventable Vaccines Market Drivers Table 241. Preventable Vaccines Market Challenges Table 242. Preventable Vaccines Market Restraints Table 243. Research Programs/Design for This Report Table 244. Key Data Information from Secondary Sources Table 245. Key Data Information from Primary Sources List of Figures Figure 1. Preventable Vaccines Product Picture Figure 2. Global Preventable Vaccines Sales Market Share by Type in 2021 & 2027 Figure 3. Adult Preventable Vaccines Product Picture Figure 4. Pediatric Preventable Vaccines Product Picture Figure 5. Global Preventable Vaccines Sales Market Share by Application in 2021 & 2027 Figure 6. Bacterial Diseases Examples Figure 7. Virus Diseases Examples Figure 8. Global Preventable Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Preventable Vaccines Sales Growth Rate (2016-2027) & (US$ Million) Figure 10. Global Preventable Vaccines Sales (K Units) Growth Rate (2016-2027) Figure 11. Global Preventable Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 12. Global Preventable Vaccines Revenue Market Share by Region: 2016 VS 2021 Figure 13. Global Preventable Vaccines Revenue Market Share by Region: 2021 VS 2027 Figure 14. North America Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 15. North America Preventable Vaccines Sales (K Units) Growth Rate (2016-2027) Figure 16. Europe Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 17. Europe Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 18. China Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 19. China Preventable Vaccines Sales (Million USD) and Growth Rate (2016-2027) Figure 20. Japan Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Japan Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 22. Southeast Asia Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 24. India Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 25. India Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 26. Global 5 Largest Preventable Vaccines Players Market Share by Revenue in Preventable Vaccines: 2016 & 2020 Figure 27. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Preventable Vaccines Revenue Share by Type (2016-2021) Figure 29. Global Preventable Vaccines Revenue Growth Rate by Type in 2016 & 2020 Figure 30. Global Preventable Vaccines Revenue Share by Application (2016-2021) Figure 31. Global Preventable Vaccines Revenue Growth Rate by Application in 2016 & 2020 Figure 32. North America Preventable Vaccines Sales Market Share by Type in 2020 Figure 33. North America Preventable Vaccines Sales Market Share by Application in 2020 Figure 34. Europe Preventable Vaccines Sales Market Share by Type in 2020 Figure 35. Europe Preventable Vaccines Sales Market Share by Application in 2020 Figure 36. China Preventable Vaccines Sales Market Share by Type in 2020 Figure 37. China Preventable Vaccines Sales Market Share by Application in 2020 Figure 38. Japan Preventable Vaccines Sales Market Share by Type in 2020 Figure 39. Japan Preventable Vaccines Sales Market Share by Application in 2020 Figure 40. Southeast Asia Preventable Vaccines Sales Market Share by Type in 2020 Figure 41. Southeast Asia Preventable Vaccines Sales Market Share by Application in 2020 Figure 42. India Preventable Vaccines Sales Market Share by Type in 2020 Figure 43. India Preventable Vaccines Sales Market Share by Application in 2020 Figure 44. Key Raw Materials Price Trend Figure 45. Manufacturing Cost Structure of Preventable Vaccines Figure 46. Manufacturing Process Analysis of Preventable Vaccines Figure 47. Preventable Vaccines Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

GlaxoSmithKline Merck Novartis Pfizer Sanofi Takeda Pharmaceutical Abbott Roche AstraZeneca Mitsubishi Tanabe Pharma Lupin Serum Institute of India LG Life Sciences S K Chemicals Shenzhen Kangtai Biological Products Sinovac Biotech Janssen Pharmaceuticals Crucell Bavarian Nordic Baxter Bharat Biotech Dynavax Bausch Health Protein Sciences Panacea Biotec